Visiting CPHI Barcelona?
Schedule a Meet

Alectinib D8

Product Information

Product Alectinib D8
CAT No. CS-CX-00065
CAS No. 1256585-15-5
Status price
Category Stable Isotopes
Mol. Wt. 490.67 mol/g
Mol. For. C₃₀H₂₆D₈N₄O₂
Hazardous This is not a Hazardous Compound

Product Description

Alectinib D8 is a deuterated form of Alectinib, a drug used in the treatment of non-small cell lung cancer (NSCLC). Alectinib D8 has the same chemical formula as Alectinib, but it contains eight deuterium atoms instead of hydrogen atoms. This makes it a useful tool for studying the pharmacokinetics and metabolism of Alectinib, as well as for improving the accuracy of pharmacokinetic studies. Alectinib D8 works by inhibiting the activity of anaplastic lymphoma kinase (ALK), which is a protein that is overactive in some types of cancer cells. By blocking the activity of ALK, Alectinib D8 helps to slow or stop the growth of cancer cells in the body. The chemical structure of Alectinib D8 consists of a pyridine ring, a pyrimidine ring, and a benzene ring. It has a molecular weight of 534.7 g/mol and a melting point of approximately 170-175°C. Alectinib D8 is administered orally in capsule form, and the recommended dosage varies depending on the individual patient's needs. It is metabolized in the liver and excreted primarily in the feces. Like all drugs, Alectinib D8 can cause side effects, including nausea, vomiting, diarrhea, fatigue, and muscle weakness. Patients taking Alectinib D8 should be closely monitored for any signs of adverse effects and should follow their doctor's instructions carefully.

Additional Information

Packing Product will be supplied in Vials, in certain conditions we also use 'Septa Vials'
Controlled No
Parent API Alectinib
Purity Not less than 90%
Isotopic Enrichment Not less than 95%
Smileys O=C1C(C2=CC=C(C#N)C=C2N3)=C3C(C)(C)C4=CC(N5CCC(N6C([2H])([2H])C([2H])([2H])OC([2H])([2H])C6([2H])[2H])CC5)=C(CC)C=C14
Hazardous No

Need a Quote?

Your email address will not be published. Required fields are marked *

Safety & Handling Information

General Information Use proper personal protective equipment
Handling Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Engineering Control Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Clothing Wear appropriate protective clothing to minimize contact with skin.
Skin Wear appropriate protective gloves and clothing to prevent skin exposure.
Eyes Wear safety glasses and chemical goggles if splashing is possible.
Inhalation Remove from exposure and move to fresh air immediately.

What we promise?

  • 30-Days Money Back
  • Complete Documentation
  • Worldwide Delivery
  • Product Accuracy

Sample Label

logo Alectinib D8 www.clearsynth.com 
 CAT : CS-CX-00065 BATCH : CSC-WWW0757

 MF: C₃₀H₂₆D₈N₄O₂
 CAS: 1256585-15-5
 Date of Anaysis: 22-Aug-2023
 Retest Date: 22-Jun-2026
MW: 490.67

Store at refrigerator (2-8C)
Qty: 60 MG 
 Only for R & D and Analytical purpose, Not for Human Consumption.

Sample Packaging

Sample Packaging

Sample Vials

Sample Vials
Product List

Related Products